Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?



Rating:

Share or cite this content

Citations should be made in the following way:
Joanna Domagała-Kulawik (Warsaw, Poland), Iwona Osinska, Anna Stelmaszczyk-Emmel, Malgorzata Proboszcz, Malgorzata Polubiec-Kownacka, Dariusz Dziedzic, Joanna Domagala-Kulawik. Correlation of IL-17A concentration with T regulatory cells in lung cancer microenvironment. Eur Respir J 2016; 48: Suppl. 60, 513

Member's Comments

No comment yet.

Related content which might interest you: Distribution of CD4+Foxp3+,CD4+ and CD8+ T cells in non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 CTLA-4 on regulatory T cells - Regulation of local immune response in lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Analysis of FOXP3 expression in the lymph nodes of patients with lung adenocarcinoma- The pilot study Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Surface expression of CTLA-4 on CD4/CD25high cells in lung cancer Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 A requirement for IKKa in lung adenocarcinoma Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Lymphocyte profile in the BALF from affected lung in comparison to healthy lung and systemic inflammation in lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Antitumor efficacy of the double suicide genesin lung cancer cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Surface vs. intracellular CTLA-4 expression in lung cancer Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 CD33+CD14-CD11b+CD66b+CD15+VEGFR-1hi myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Effect of 17-oxo-DHA alone and in combination with gemcitabine on lung cancer cell growth Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016 Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 The prognostic impact of PD1 and PDL1 expression in non-small cell lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Exploring the volatome of different cancer cell lines Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Comparative analysis of lymphoid subsets in peripheral blood and tumor-infiltrating lymphocytes of lung cancer patients Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Immunoglobulin-like transcripts 3 (ILT3) expression in human lung adenocarcinoma as a novel regulator of intratumoral lymphoid follicle formation Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Roles of polarized neutrophils on lung tumour development in an orthotopic lung tumour mouse model Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Role of hypoxia in epithelial-to-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Mouse lung adenocarcinoma cell lines reveal Prl2c2 as a novel lung tumor promoter Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015